Cite
HARVARD Citation
Otani, Y. et al. (n.d.). CSIG-17. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENT. Neuro-oncology. p. ii31. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Otani, Y. et al. (n.d.). CSIG-17. PRMT5 INHIBITION SENSITIZES GLIOBLASTOMA MODELS TO TRAMETINIB TREATMENT. Neuro-oncology. p. ii31. [Online].